| Product Code: ETC10797218 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Poland Pharmacogenomics Technology Market Overview |
3.1 Poland Country Macro Economic Indicators |
3.2 Poland Pharmacogenomics Technology Market Revenues & Volume, 2021 & 2031F |
3.3 Poland Pharmacogenomics Technology Market - Industry Life Cycle |
3.4 Poland Pharmacogenomics Technology Market - Porter's Five Forces |
3.5 Poland Pharmacogenomics Technology Market Revenues & Volume Share, By Technology Type, 2021 & 2031F |
3.6 Poland Pharmacogenomics Technology Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Poland Pharmacogenomics Technology Market Revenues & Volume Share, By Testing Method, 2021 & 2031F |
3.8 Poland Pharmacogenomics Technology Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.9 Poland Pharmacogenomics Technology Market Revenues & Volume Share, By Market Driver, 2021 & 2031F |
3.9.1 Increasing adoption of personalized medicine in Poland |
3.9.2 Growing prevalence of chronic diseases driving the need for personalized treatment |
3.9.3 Government initiatives and funding to promote pharmacogenomics technology in healthcare |
4 Poland Pharmacogenomics Technology Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
4.3.1 High costs associated with pharmacogenomics testing and technology |
4.3.2 Limited awareness and understanding of pharmacogenomics among healthcare professionals |
4.3.3 Regulatory challenges and reimbursement issues related to pharmacogenomics services |
5 Poland Pharmacogenomics Technology Market Trends |
6 Poland Pharmacogenomics Technology Market, By Types |
6.1 Poland Pharmacogenomics Technology Market, By Technology Type |
6.1.1 Overview and Analysis |
6.1.2 Poland Pharmacogenomics Technology Market Revenues & Volume, By Technology Type, 2021 - 2031F |
6.1.3 Poland Pharmacogenomics Technology Market Revenues & Volume, By Genotyping, 2021 - 2031F |
6.1.4 Poland Pharmacogenomics Technology Market Revenues & Volume, By Next-Generation Sequencing, 2021 - 2031F |
6.1.5 Poland Pharmacogenomics Technology Market Revenues & Volume, By Gene Expression Profiling, 2021 - 2031F |
6.1.6 Poland Pharmacogenomics Technology Market Revenues & Volume, By Bioinformatics Solutions, 2021 - 2031F |
6.1.7 Poland Pharmacogenomics Technology Market Revenues & Volume, By Companion Diagnostics, 2021 - 2031F |
6.2 Poland Pharmacogenomics Technology Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Poland Pharmacogenomics Technology Market Revenues & Volume, By Personalized Medicine, 2021 - 2031F |
6.2.3 Poland Pharmacogenomics Technology Market Revenues & Volume, By Drug Response Analysis, 2021 - 2031F |
6.2.4 Poland Pharmacogenomics Technology Market Revenues & Volume, By Oncology Treatment, 2021 - 2031F |
6.2.5 Poland Pharmacogenomics Technology Market Revenues & Volume, By Adverse Drug Reactions, 2021 - 2031F |
6.2.6 Poland Pharmacogenomics Technology Market Revenues & Volume, By Clinical Trials, 2021 - 2031F |
6.3 Poland Pharmacogenomics Technology Market, By Testing Method |
6.3.1 Overview and Analysis |
6.3.2 Poland Pharmacogenomics Technology Market Revenues & Volume, By PCR-Based, 2021 - 2031F |
6.3.3 Poland Pharmacogenomics Technology Market Revenues & Volume, By Microarray, 2021 - 2031F |
6.3.4 Poland Pharmacogenomics Technology Market Revenues & Volume, By Whole Genome Sequencing, 2021 - 2031F |
6.3.5 Poland Pharmacogenomics Technology Market Revenues & Volume, By AI-Based Analytics, 2021 - 2031F |
6.3.6 Poland Pharmacogenomics Technology Market Revenues & Volume, By DNA Microarray, 2021 - 2031F |
6.4 Poland Pharmacogenomics Technology Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 Poland Pharmacogenomics Technology Market Revenues & Volume, By Pharma Companies, 2021 - 2031F |
6.4.3 Poland Pharmacogenomics Technology Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.4.4 Poland Pharmacogenomics Technology Market Revenues & Volume, By Research Labs, 2021 - 2031F |
6.4.5 Poland Pharmacogenomics Technology Market Revenues & Volume, By Academic Institutions, 2021 - 2031F |
6.4.6 Poland Pharmacogenomics Technology Market Revenues & Volume, By Diagnostic Centers, 2021 - 2031F |
6.5 Poland Pharmacogenomics Technology Market, By Market Driver |
6.5.1 Overview and Analysis |
6.5.2 Poland Pharmacogenomics Technology Market Revenues & Volume, By Advancements in Precision Medicine, 2021 - 2031F |
6.5.3 Poland Pharmacogenomics Technology Market Revenues & Volume, By Increase in Genetic Testing, 2021 - 2031F |
6.5.4 Poland Pharmacogenomics Technology Market Revenues & Volume, By Growing Interest in Targeted Therapy, 2021 - 2031F |
6.5.5 Poland Pharmacogenomics Technology Market Revenues & Volume, By Expansion in Pharmacovigilance, 2021 - 2031F |
6.5.6 Poland Pharmacogenomics Technology Market Revenues & Volume, By Demand for Tailored Therapeutics, 2021 - 2031F |
7 Poland Pharmacogenomics Technology Market Import-Export Trade Statistics |
7.1 Poland Pharmacogenomics Technology Market Export to Major Countries |
7.2 Poland Pharmacogenomics Technology Market Imports from Major Countries |
8 Poland Pharmacogenomics Technology Market Key Performance Indicators |
8.1 Number of healthcare facilities offering pharmacogenomics services |
8.2 Percentage of healthcare professionals trained in pharmacogenomics technology |
8.3 Rate of adoption of pharmacogenomics testing in clinical practice |
9 Poland Pharmacogenomics Technology Market - Opportunity Assessment |
9.1 Poland Pharmacogenomics Technology Market Opportunity Assessment, By Technology Type, 2021 & 2031F |
9.2 Poland Pharmacogenomics Technology Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Poland Pharmacogenomics Technology Market Opportunity Assessment, By Testing Method, 2021 & 2031F |
9.4 Poland Pharmacogenomics Technology Market Opportunity Assessment, By End User, 2021 & 2031F |
9.5 Poland Pharmacogenomics Technology Market Opportunity Assessment, By Market Driver, 2021 & 2031F |
10 Poland Pharmacogenomics Technology Market - Competitive Landscape |
10.1 Poland Pharmacogenomics Technology Market Revenue Share, By Companies, 2024 |
10.2 Poland Pharmacogenomics Technology Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here